1 Min Read
May 24 (Reuters) - Allergan Plc
* Allergan announces FDA acceptance of NDA filing for oxymetazoline hci cream 1.0%
* Says expects PDUFA date in first half 2017 Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.